The world’s best-selling drug is in line for cheaper competition — eventually

(By Damian Garde for STAT)

The Food and Drug Administration on Friday approved a lower-cost version of the world’s top-selling drug, but don’t expect to see it at the pharmacy any time soon. Continue reading article here……

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.